ERBB2 and breast cancer: In HER2-negative BC, the following [18F]FDG PET-based features were significantly different between the pCR and non-pCR tumors: uniformity (lower in patients with pCR); entropy, SUVmax, SUVmean, SUVmedian, range, SD and CoV (higher in patients with pCR).